Similarly, progress in PDGFR signaling in glioma would greatly benefit from an in vivo model that is based on clinically relevant parameters such as overexpression of PDGFRα and its chronic stimulation by PDGF-A ligand. The gene discussed is PDGFA; the disease is glioma.